Skip to main content

Table 3 The impact of HER2-low expression on breast cancer-specific survival

From: Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

 

Breast cancer-specific survival

Before IPTW

After IPTW

HRs (95% CI)

P value

HRs (95% CI)

P value

Hormone receptor-positive

0.72 (0.44–1.17)

.188

0.72 (0.44–1.17)

.187

Hormone receptor-negative

0.64 (0.38–1.09)

.098

0.61 (0.35–1.05)

.075